Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| regulatory T cell | 24 studies | 31% ± 10% | |
| type I pneumocyte | 12 studies | 59% ± 21% |
Insufficient scRNA-seq data for expression of RTKN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 5072.16 | 577 / 578 | 94% | 5.28 | 1091 / 1155 |
| prostate | 84% | 159.48 | 205 / 245 | 79% | 1.59 | 397 / 502 |
| skin | 82% | 166.00 | 1485 / 1809 | 71% | 2.05 | 333 / 472 |
| breast | 55% | 71.75 | 252 / 459 | 93% | 3.94 | 1043 / 1118 |
| intestine | 50% | 142.26 | 483 / 966 | 91% | 3.32 | 482 / 527 |
| stomach | 46% | 66.14 | 164 / 359 | 88% | 3.31 | 252 / 286 |
| esophagus | 40% | 592.72 | 579 / 1445 | 90% | 4.96 | 165 / 183 |
| ovary | 36% | 41.52 | 65 / 180 | 93% | 3.03 | 398 / 430 |
| uterus | 29% | 47.73 | 49 / 170 | 95% | 7.38 | 436 / 459 |
| bladder | 33% | 33.29 | 7 / 21 | 87% | 4.49 | 439 / 504 |
| thymus | 72% | 113.50 | 473 / 653 | 39% | 1.59 | 234 / 605 |
| brain | 41% | 61.00 | 1077 / 2642 | 64% | 1.93 | 449 / 705 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.86 | 1 / 1 |
| spleen | 97% | 199.07 | 233 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 7.82 | 42 / 45 |
| pancreas | 2% | 2.05 | 8 / 328 | 89% | 3.72 | 158 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 76% | 2.79 | 22 / 29 |
| kidney | 42% | 71.45 | 37 / 89 | 17% | 0.32 | 154 / 901 |
| peripheral blood | 41% | 63.67 | 380 / 929 | 0% | 0 | 0 / 0 |
| adipose | 32% | 33.68 | 386 / 1204 | 0% | 0 | 0 / 0 |
| liver | 1% | 0.50 | 2 / 226 | 20% | 0.42 | 83 / 406 |
| blood vessel | 9% | 10.49 | 116 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 0.51 | 2 / 258 | 7% | 0.12 | 15 / 230 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.06 | 4 / 80 |
| heart | 2% | 2.04 | 21 / 861 | 0% | 0 | 0 / 0 |
| muscle | 1% | 0.70 | 6 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
| GO_2001243 | Biological process | negative regulation of intrinsic apoptotic signaling pathway |
| GO_0030097 | Biological process | hemopoiesis |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| Gene name | RTKN2 |
| Protein name | Rhotekin-2 (Pleckstrin homology domain-containing family K member 1) (PH domain-containing family K member 1) Rhotekin 2 |
| Synonyms | PLEKHK1 |
| Description | FUNCTION: May play an important role in lymphopoiesis. . |
| Accessions | ENST00000373789.8 [Q8IZC4-1] ENST00000315289.6 Q8IZC4 ENST00000395260.3 [Q8IZC4-3] Q5SVY4 |